Navamedic ASA Financial report for Q1 2012
Navamedic's first quarter 2012 revenues saw a 22 per cent growth over the same period last year. Revenues were NOK 20.6 million compared to NOK 16.8 million in 2011. EBITDA for the first quarter reached NOK 0.1 million, compared to NOK -1.0 million in the same period of 2011. Eight generic products are authorized for marketing in the last two quarters of 2012.
| Group | Group | ||
| (in NOK '000) | Q1 2012 | Q1 2011 | FY 2011 |
| Revenues | 20.588 | 16.778 | 71.299 |
| Gross Profit | 8.265 | 6.672 | 29.272 |
| Gross margin | 40% | 40% | 41% |
| EBITDA | 58 | -982 | -2.639 |
| EBIT | -1.500 | -2.669 | -9.359 |
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
The full report with tables and the presentation can be downloaded from the following links: